Purisima, Veronica B.
HRN: 25-06-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2024
CEFTRIAXONE 1G (VIAL)
05/21/2024
05/28/2024
IV
2g
Daily
Pelvic Mass, T/C Pelvic Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes